References
- ABE, K., HORIUCHI, M. and YOSHINIURA, K., 1995, Cognitive enhancing effect of S-8510, a novel benzodiazepine partial inverse agonist, on event related potential (P300) in monkeys. Japanese Journal of Pharmacology, 67 (suppl. 1), 152.
- BRAESTRAP, C., NIELSEN, M., HONORE, T., JENSEN, L. H. and PETERSEN, E. N., 1983, Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology, 22, 1451–1457.
- BRAESTRAP, C., SCHMIECHEN, R., NF, G., NIELSEN, M. and PETERSEN, E. N., 1982, Interaction of convulsive ligands with benzodiazepine receptors. Science, 216, 1241–1243.
- BROWN, C. D., WONG, B. A. and FENNELL, T. R., 1996, In vivo and in vitro kinetics of ethylene oxide metabolism in rats and mice. Toxicology and Applied Pharmacology, 136, 8–19.
- COLE, B. J. and HILLMANN, M., 1994, Effects of benzodiazepine receptor ligands on the performance of an operant delayed matching to position task in rats: opposite effects of FG 7142 and lorazepam. Psychopharmacology, 115, 350–357.
- DUKA, T., STEPHENS, D. N., KRAUSE, W. and DOROW, R., 1987, Human studies on the benzodiazepine receptor antagonist b-carboline ZK 93426: preliminary observations on psychotropic activity. Psychopharmacology, 93, 421–427.
- FEDTKE, N., CERTA, H., EBERT, R. and WIEGAND, H.-J., 1994, Species differences in the bio-transformation of ethyl chloride. Archives of Toxicology, 68, 158–166.
- FISHER, R. L., HASAL, S. J., SIPES, I. G., GANDow, A. J. and BRENDEL, K., 1995, Comparative metabolism and toxicity of dichlorobenzenes in Sprague-Dawley, Fischer-344 and human liver slices. Human and Experimental Toxicology, 14, 414–421.
- GUENGERICH, F. P., 1988, Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Research, 48, 2946–2954.
- GOLDEN, G. T., SMITH, G. G., FERRARO, T. N. and Rs, P. F., 1995, Rat strain and age differences in kainic acid induced seizures. Epilepsy Research, 20, 151–159.
- HISSINK, A. M., OUDSHOORN, M. J., VAN OMIVIEN, B. and VAN BLADEREN, P. J., 1997, Species and strain differences in the hepatic cytochrome P450-mediated biotransformation of 1,4-dichlorobenzene. Toxicology and Applied Pharmacology, 145, 1–9
- JACKSON, H. C. and NUTT, D. J., 1992, Strain differences in sensitivity to the hypothermic effects of benzodiazepine receptor ligands in mice. Psychopharmacology, 109, 365–368.
- KAWASAKI, K., KIHARA, T., MURATA, S., KOIKE, K., IKEDA, M., EIGYO, M. and TAKADA, S., 1996, A novel benzodiazepine partial inverse agonist, S-8510, as a cognitive enhancer. In GABA: Receptors, Transporters and Metabolism, edited by C. Tanaka and N. G. Bowery (Switzerland: Birkliiuser Verlag Basel), pp. 259–266.
- NAITO, Y., TAKEUCHI, M., KIHARA, T., IKEDA, M., IBII, N. and MATSUSIT A., 1995, Electro-encephalographic (EEG) properties of S-8510, a novel benzodiazepine partial inverse agonist, in rats. Japanese Journal of Pharmacology, 67, (suppl. 1), 151.
- NUTT, D. J. and LISTER, R. G., 1989, Antagonizing the anticonvulsant effect of ethanol using drugs acting at the benzodiazepine/GABA receptor complex. Pharmacology Biochemistry and Behavior, 31, 751–755.
- PELKONEN, O. and NEVERT, D. W., 1982, Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacological Review, 34, 189–222.
- POLC, P., BONETTI, E. P., SCHAFFNER, R. and HAEFELY, W., 1982, A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, /3-carbolines, and phenobarbitone. Naunyn-Schmiedeberg's Archives of Pharmacology, 321, 260–264.
- SLAUTER, R. W., COLEMAN, D. P., GAUDETTE, N. F, McKEE, R. H., MASTEN, L. W., GARDINER, T. H., STROTHER, D. E., TYLER, T. R. AND JEFFCOAT, A. R., 1994, Disposition and pharmacokinetics of isopropanol in F-344 rats and B6C3F1 mice. Fundamental and Applied Toxicology, 23, 407–420.
- WAROT, D., DANJOU, P., DOUILLET, P., KEANE, P. and PUECH, A. J., 1994, Cognitive impairments induced by triazolam in healthy volunteers. Therapie, 49, 23–26.